Princeton Capital Management Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $1.7M | Buy |
3,791
+1,280
| +51% | +$572K | 0.86% | 36 |
|
|
2017
Q2 | $1.23M | Buy |
2,511
+15
| +0.6% | +$7.37K | 0.78% | 39 |
|
|
2017
Q1 | $967K | Buy |
2,496
+157
| +7% | +$60.8K | 0.61% | 45 |
|
|
2016
Q4 | $859K | Buy |
2,339
+104
| +5% | +$38.2K | 0.57% | 40 |
|
|
2016
Q3 | $899K | Buy |
2,235
+284
| +15% | +$114K | 0.59% | 44 |
|
|
2016
Q2 | $681K | Buy |
1,951
+1,140
| +141% | +$398K | 0.47% | 46 |
|
|
2016
Q1 | $292K | Buy |
+811
| New | +$292K | 0.2% | 61 |
|